Phase 3 Dose Selection for Selinexor in Tp53Wt Endometrial Cancer Based on Exposure-Response Analysis.

AuthID
P-017-VJW
14
Author(s)
Makker, V
·
Richardson, DL
·
Chon, HS
·
Mau-Sørensen, M
·
Cibula, D
·
Zagouri, F
·
Pérez Fidalgo, A
·
Slomovitz, BM
·
Coleman, RL
·
Kalyanapu, P
·
Fan, R
·
Gudi, G
·
Vergote, I
Document Type
Article
Year published
2024
Published
in Journal of Clinical Oncology, ISSN: 0732-183X
Volume: 42, Issue: 16_suppl, Pages: 5594-5594
Indexing
Publication Identifiers
Source Identifiers
ISSN: 0732-183X
Export Publication Metadata
Marked List
Info
At this moment we don't have any links to full text documens.